Classification of a palliative care population in a comprehensive XXXX centre.

@entity5 @entity1 @entity0
PURPOSE: The purposes of the present study were to classify the palliative care population (PCP) in a comprehensive @entity5 centre by using information on antineoplastic treatment options and to analyse associations between socio-demographic factors, @entity5 diagnoses, treatment characteristics and receiving specialist palliative care (SPC). METHODS: This is a cross-sectional screening study of @entity1 with @entity5 in the Department of Oncology, Rigshospitalet, Copenhagen University Hospital for 6  months. @entity1 were assessed to be included in the DOMUS study: a randomised controlled trial of accelerated transition to SPC at home (NCT01885637). The PCP was classified as @entity1 with incurable @entity5 and limited or no antineoplastic treatment options. @entity1 with performance status 2-4 were further classified as the essential palliative care population (EPCP). RESULTS: During the study period, 3717 @entity1 with @entity5 were assessed. The PCP comprised 513 @entity1 yielding a prevalence of 14  %. The EPCP comprised 256 @entity1 (7  %). The EPCP was older, more likely inpatients, had a higher comorbidity burden and 38  % received SPC. @entity1 , @entity1 without caregivers and @entity1 with @entity0 were more likely to receive SPC. CONCLUSIONS: By using objective criteria from clinical data and systematic screening, the observed prevalence of the PCP of 14  % may be generalisable to comprehensive @entity5 centres with similar composition of @entity5 diagnoses.
